Important Investor Alert for Orthofix Medical, Inc.
Kahn Swick & Foti, LLC has issued a significant reminder to shareholders of Orthofix Medical, Inc. regarding their rights in a pending class action lawsuit. If you are an investor who has suffered losses exceeding $100,000 due to investments in Orthofix, it’s crucial to be aware of the deadlines involved in this legal case. Investors have until October 21, 2024, to apply as lead plaintiffs in this matter.
Understanding the Class Action
This legal action pertains to investors who purchased shares of Orthofix between October 11, 2022, and September 12, 2023. During this Class Period, several critical disclosures were allegedly withheld, impacting investors' decisions and financial outcomes. If you believe that you may be eligible to join this suit, contacting Kahn Swick & Foti could be an important step toward seeking compensation.
Your Next Steps as an Investor
If you hold shares of Orthofix and are keen to discuss your legal options, KSF Managing Partner, Lewis Kahn, is available for consultations at no initial cost. You can reach out to him by calling 1-877-515-1850. Furthermore, further details can be obtained directly from KSF's platform.
Context of the Lawsuit
Investors’ concerns escalated following a major announcement by Orthofix on September 12, 2023. The company disclosed that it had appointed an interim CEO, CFO, and CLO after a decisive board meeting resulted in the termination of several executives. This decision was based on findings from an independent investigation that revealed inappropriate conduct by the former executives, calling into question the company's governance and operational integrity.
Impacts on Orthofix's Share Prices
Following the revelation of these events, Orthofix's share price suffered a significant drop, declining by over 30% in value within a single day. Such a steep decrease indicates the extent to which investor confidence was shaken by the internal issues at the firm. Each investor’s situation can vary, so addressing your legal rights early on is essential.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, known widely as KSF, stands out in the realm of securities litigation. This prominent law firm is led by former Louisiana Attorney General Charles C. Foti, Jr., and focuses exclusively on assisting clients recover losses tied to corporate misconduct. Serving an array of investors from institutional to retail, KSF prioritizes transparency and client rights throughout its operations.
Connect with KSF for More Information
For more about their services and how they can assist you through this legal navigating process, you can visit KSF's official website. They specialize in ensuring that clients are empowered in their quest for justice.
Frequently Asked Questions
What is the deadline to file for lead plaintiff status?
The deadline to file for lead plaintiff status in the Orthofix class action lawsuit is October 21, 2024.
How can I determine if I qualify to join the lawsuit?
If you purchased shares during the specified Class Period and incurred losses, you may qualify. Contact Kahn Swick & Foti for a consultation.
What were the key events leading to the lawsuit?
The lawsuit arises from allegations that Orthofix withheld critical information about executive conduct that impacted share prices, leading to substantial losses for investors.
Who is Kahn Swick & Foti, LLC?
Kahn Swick & Foti is a national law firm specializing in securities litigation and investor rights, founded by former Louisiana Attorney General Charles C. Foti, Jr.
How can I get in touch with KSF?
You can reach Lewis Kahn of KSF at 1-877-515-1850 or through their official website.
